Scholars@Duke
Journal cover image

Androgen Deprivation Monotherapy for Localized Prostate Cancer: Can It Be Justified?

Publication ,  Journal Article
Ovadia, A; Abern, M
Published in: Eur Urol
July 2015
Published version (DOI) Link to item

Duke Scholars

Michael R Abern
Author Michael R Abern Urology

Published In

Eur Urol

DOI

10.1016/j.eururo.2014.10.046

EISSN

1873-7560

Publication Date

July 2015

Volume

68

Issue

1

Start / End Page

40 / 41

Location

Switzerland

Related Subject Headings

  • Urology & Nephrology
  • Registries
  • Prostatic Neoplasms
  • Orchiectomy
  • Male
  • Humans
  • Antineoplastic Agents, Hormonal
  • Androgen Antagonists
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ovadia, A., & Abern, M. (2015). Androgen Deprivation Monotherapy for Localized Prostate Cancer: Can It Be Justified? Eur Urol, 68(1), 40–41. https://doi.org/10.1016/j.eururo.2014.10.046
Ovadia, Aaron, and Michael Abern. “Androgen Deprivation Monotherapy for Localized Prostate Cancer: Can It Be Justified?” Eur Urol 68, no. 1 (July 2015): 40–41. https://doi.org/10.1016/j.eururo.2014.10.046.
Ovadia, Aaron, and Michael Abern. “Androgen Deprivation Monotherapy for Localized Prostate Cancer: Can It Be Justified?” Eur Urol, vol. 68, no. 1, July 2015, pp. 40–41. Pubmed, doi:10.1016/j.eururo.2014.10.046.
Journal cover image

Published In

Eur Urol

DOI

10.1016/j.eururo.2014.10.046

EISSN

1873-7560

Publication Date

July 2015

Volume

68

Issue

1

Start / End Page

40 / 41

Location

Switzerland

Related Subject Headings

  • Urology & Nephrology
  • Registries
  • Prostatic Neoplasms
  • Orchiectomy
  • Male
  • Humans
  • Antineoplastic Agents, Hormonal
  • Androgen Antagonists
  • 3202 Clinical sciences
  • 1103 Clinical Sciences